News

Sustainable Medicines Manufacturing Innovation: Collaborative R&D

Sustainable Medicines Manufacturing Innovation: Collaborative R&D

Innovate UK, part of UK Research and Innovation, will work with the Department of Health and Social Care (DHSC) to invest up to £15 million to support the development and adoption of sustainable technologies for the manufacturing of medicines.

Funding, Opportunities
Funding news

Innovate UK, part of UK Research and Innovation, will work with the Department of Health and Social Care (DHSC) to invest up to £15 million to support the development and adoption of sustainable technologies for the manufacturing of medicines. This funding is part of the Sustainable Medicines Manufacturing Innovation Programme.

The aim of this competition is to drive innovation in sustainable medicines manufacturing across three key pillars:

 

  • green chemistry
  • circularity
  • productivity and resource efficiency

You must also consider both critical enablers:

 

  • regulations: how to overcome any regulatory barriers to adoption of your innovation
  • measurements, standards and data: approaches to capture data that support the measurement and reporting of sustainability indicators aligned with industry standards

 

These new manufacturing innovations are expected to support more environmentally sustainable manufacturing processes with significant and measurable improvements in at least one of the following areas:

 

 

  • productivity
  • waste reduction
  • emissions reduction
  • energy use reduction
  • resource efficiency

 

You must also consider how to overcome any regulatory barriers to adoption of your innovation, alongside approaches to capture data that support the measurement and reporting of sustainability indicators aligned with industry standards.

Your proposal must show how your project will improve the productivity, competitiveness and growth for at least one UK micro, small or medium-sized enterprise (SME) involved in the project.

 

We define sustainable medicines manufacturing as the process of producing medicines in a manner that minimises environmental impact, conserves natural resources, and ensures economic and social sustainability. This approach focuses on reducing waste, energy consumption and emissions, while enhancing efficiency, safety, and cost-effectiveness throughout the manufacturing lifecycle. It also includes the adoption of innovative technologies and practices that promote the long-term viability of the medicines manufacturing industry.

 

 

In applying to this competition, you are entering into a competitive process. This competition has a funding limit, so we may not be able to fund all the proposed projects. It may be the case that your project scores highly but we are still unable to fund it.

 

This competition closes at 11am UK time on the deadline stated in this Innovate UK competition brief. We cannot guarantee other government or third party sites will always show the correct competition information.

Funding type

Grant

Project size

Your project’s total grant funding request must be between £500,000 and £2 million.

Accessibility and Inclusion

We welcome and encourage applications from people of all backgrounds and are committed to making our application process accessible to everyone. This includes making reasonable adjustments, for people who have a disability or a long-term condition and face barriers applying to us.

You can contact us at any time to ask for guidance.

We recommend you contact us at least 15 working days before this competition’s closing date to allow us to put the most suitable support in place. The support we can provide may be limited if you contact us close to the competition deadline.

You can contact Innovate UK by email or call 0300 321 4357. Our phone lines are open from 9am to 12pm and 2pm to 5pm UK time, Monday to Friday (excluding bank holidays).

NEWS​

Related News

Gnomon Informatics Kicks Off 2025 with a Strong Presence at Arab Health & Athens Digital Health Week!

4 Feb 2025
January was a dynamic month for Gnomon Informatics, as we showcased our innovations in digital health at two major industry events—Arab Health and Ath...

Postmodern EHR: Evolution, not revolution

4 Feb 2025
Once hailed as revolutionary, the traditional monolithic Electronic Health Record (EHR) systems now show limitations. These mega suites were designed ...

Publication by DTH-Lab & Data Solidarity Project team University of Vienna: Data solidarity operationalising public value through a digital tool

4 Feb 2025
Data governance isn't just about rules—it's about people. In this article, DTH-Lab Director, Ilona Kickbusch with co-authors Barbara Prainsack and Sel...

Digital Health Compliance Trends: Top Standards for 2025

4 Feb 2025
A study of digital health innovators asked which standards they plan to meet in 2025. Benchmark your compliance plans, by reading our article to disco...

HLTH Community & Novartis Present Latest Industry Report: Unblocking Innovations in Drug Development

4 Feb 2025
The HLTH Community & Novartis report, Unblocking Innovations in Drug Development, dives into the critical challenges hindering AI and digital inno...

Evondos Group – attending events and exhibitions in both the UK and Spain this spring

4 Feb 2025
Are you curious to test out and see the latest welfare technology that is taking the Nordics by storm? Don't miss out on which events and exhibitions ...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *